MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-15-2026
ENDRA Life Sciences Shares 2011-2026 | NDRA
Annual Shares ENDRA Life Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 787 K | 202 K | 5.94 K | 3.17 M | 2.13 M | 19.2 M | 7.5 M | 4.5 M | 2.76 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.2 M | 5.94 K | 4.47 M |
Quarterly Shares ENDRA Life Sciences
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 M | 761 K | 752 K | 562 K | 537 K | 247 K | 72.4 M | 10.9 M | 10.4 M | 8.41 M | 7.48 M | 3.17 M | 3.17 M | 63.2 M | 63.2 M | 43.1 M | 42.6 M | 41.9 M | 41.7 M | 37.8 M | 34 M | 23.9 M | 14.7 M | 11.5 M | 8.42 M | 7.43 M | 7.42 M | 7.42 M | 7.42 M | 3.93 M | 3.92 M | 3.92 M | 3.92 M | 3.91 M | 2.44 M | 723 K | 723 K | 723 K | 723 K | 723 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 72.4 M | 247 K | 15 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
29 M | $ 20.41 | 1.9 % | $ 592 M |  USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 17.34 | 5.67 % | $ 524 M | USA |
 |
Guardant Health
GH
|
125 M | $ 118.55 | 3.11 % | $ 14.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 115.14 | 0.04 % | $ 9.5 B |  Irlanda |
 |
Illumina
ILMN
|
159 M | $ 144.35 | 1.71 % | $ 23 B | USA |
 |
Agilent Technologies
A
|
304 M | $ 113.97 | 0.21 % | $ 34.6 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 141.62 | 0.91 % | $ 6.62 B | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 3.88 | 62.44 % | $ 5.16 M | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 21.66 | 2.39 % | $ 1.15 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 94.6 | -1.56 % | $ 6.38 B | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 1.8 | - | $ 7.96 M | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 424.51 | 0.63 % | $ 12.2 B | USA |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 086.52 | 0.31 % | $ 22.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Natera
NTRA
|
98.4 M | $ 204.45 | -0.23 % | $ 20.1 B | USA |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Personalis
PSNL
|
89.2 M | $ 8.3 | 4.4 % | $ 741 M | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 159.56 | 2.22 % | $ 7.91 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
128 M | $ 8.96 | 0.67 % | $ 1.15 B | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 19.06 | -1.04 % | $ 427 M | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 3.81 | -0.13 % | $ 353 M | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 448.97 | -0.59 % | $ 169 B | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
948 M | $ 27.16 | 1.61 % | $ 25.8 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | $ 55.04 | 2.57 % | $ 3.29 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 5.96 | 4.38 % | $ 249 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
50.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.41 | 2.55 % | $ 5.54 M | USA |
 |
Waters Corporation
WAT
|
59.5 M | $ 339.58 | -0.48 % | $ 20.2 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 254.26 | -1.19 % | $ 21.2 B | USA |
 |
Trinity Biotech plc
TRIB
|
359 M | $ 0.62 | 2.96 % | $ 223 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Exagen
XGN
|
21.6 M | $ 4.06 | 6.01 % | $ 87.5 M | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 8.77 | -0.68 % | $ 1.9 B | USA |